Insulet (PODD) EPS (Basic) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Insulet (PODD) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | -47.75% |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 25.48% |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 41.56% |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 43.85% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 14.55% |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | -25.84% |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 42.13% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 13.85% |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn | 328.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 328.87% |
| Mar 31, 2026 | 157.67% |
| Dec 31, 2025 | 0.60% |
| Sep 30, 2025 | 12.64% |
| Jun 30, 2025 | -88.13% |
| Mar 31, 2025 | -31.38% |
| Dec 31, 2024 | -3.06% |
| Sep 30, 2024 | 48.69% |
| Jun 30, 2024 | 587.68% |
| Mar 31, 2024 | 115.23% |
| Dec 31, 2023 | 504.96% |
| Sep 30, 2023 | 1,092.29% |
| Jun 30, 2023 | 177.57% |
| Mar 31, 2023 | -14.79% |
| Dec 31, 2022 | -43.19% |
| Sep 30, 2022 | -140.94% |
| Jun 30, 2022 | -34.63% |
| Dec 31, 2021 | 263.29% |
| Sep 30, 2021 | 3.65% |
| Jun 30, 2021 | -267.56% |